WAM
TECH icon

Wolverine Asset Management’s Bio-Techne TECH Stock Holding History

Wolverine Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,056
Closed -$343K – 2349
2021
Q2 		$343K Buy
+3,056
New +$322K ﹤0.01% 1054

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Wolverine Asset Management's TECH Position: Q3 2021 in Review

Wolverine Asset Management sold out of Bio-Techne (TECH) in Q3 2021, closing a stake of 3,056 shares — an estimated $343K sold.

Wolverine Asset Management first reported a position in TECH in Q2 2021 and held it in 1 quarter. The position peaked at $343K in Q2 2021. 565 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

  • Wolverine Asset Management reported no remaining Bio-Techne position as of Q3 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 3,056 Bio-Techne shares in Q3 2021, an estimated $343K.
  • Wolverine Asset Management first reported a position in Bio-Techne in Q2 2021 and held it in 1 quarter.
  • Wolverine Asset Management's Bio-Techne position peaked at $343K in Q2 2021.
  • 565 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.